AAAAAA
Results:
1-13
|
Results: 13
Authors:
Fischer, JS
Priore, RL
Jacobs, LD
Cookfair, DL
Rudick, RA
Herndon, RM
Richert, JR
Salazar, AM
Goodkin, DE
Granger, CV
Simon, JH
Grafman, JH
Lezak, MD
Hovey, KMO
Perkins, KK
Barilla-Clark, D
Schacter, M
Shucard, DW
Davidson, AL
Wende, KE
Bourdette, DN
Kooijmans-Coutinho, MF
Citation: Js. Fischer et al., Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis, ANN NEUROL, 48(6), 2000, pp. 885-892
Authors:
Simon, JH
Lull, J
Jacobs, LD
Rudick, RA
Cookfair, DL
Herndon, RM
Richert, JR
Salazar, AM
Sheeder, J
Miller, D
McCabe, K
Serra, A
Campion, MK
Fischer, JS
Goodkin, DE
Simonian, N
Lajaunie, M
Wende, K
Martens-Davidson, A
Kinkel, RP
Munschauer, FE
Citation: Jh. Simon et al., A longitudinal study of T1 hypointense lesions in relapsing MS - MSCRG trial of interferon beta-1a, NEUROLOGY, 55(2), 2000, pp. 185-192
Authors:
Herndon, RM
Citation: Rm. Herndon, Interferons in the treatment of multiple sclerosis: Errors and misrepresentations, ARCH NEUROL, 57(3), 2000, pp. 426-427
Authors:
Herndon, RM
Citation: Rm. Herndon, Pathology and pathophysiology, MULTIPLE SCLEROSIS: DIAGNOSIS, MEDICAL MANAGEMENT, AND REHABILITATION, 2000, pp. 35-45
Authors:
Herndon, RM
Horak, F
Citation: Rm. Herndon et F. Horak, Vertigo, imbalance, and incoordination, MULTIPLE SCLEROSIS: DIAGNOSIS, MEDICAL MANAGEMENT, AND REHABILITATION, 2000, pp. 333-339
Authors:
Herndon, RM
Citation: Rm. Herndon, Is Alexander's disease a nosologic entity or a common pathologic pattern of diverse etiology?, J CHILD NEU, 14(5), 1999, pp. 275-276
Authors:
Rudick, RA
Goodman, A
Herndon, RM
Panitch, HS
Citation: Ra. Rudick et al., Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment, J NEUROIMM, 98(1), 1999, pp. 22-28
Authors:
Rudick, RA
Cookfair, DL
Simonian, NA
Ransohoff, RM
Richert, JR
Jacobs, LD
Herndon, RM
Salazar, AM
Fischer, JS
Granger, CV
Goodkin, DE
Simon, JH
Bartoszak, DM
Bourdette, DN
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munchsauer, FE
O'Reilly, K
Priore, RL
Pullicino, PM
Scherokman, BJ
Wende, K
Weinstock-Guttman, B
Whitham, RH
Citation: Ra. Rudick et al., Cerebrospinal fluid abnormalities in a phase III trial of Avonex (R) (IFN beta-1a) for relapsing multiple sclerosis, J NEUROIMM, 93(1-2), 1999, pp. 8-14
Authors:
Herndon, RM
Citation: Rm. Herndon, Interferon beta treatment for multiple sclerosis, LANCET, 353(9151), 1999, pp. 494-495
Authors:
Simon, JH
Jacobs, LD
Campion, MK
Rudick, RA
Cookfair, DL
Herndon, RM
Richert, JR
Salazar, AM
Fischer, JS
Goodkin, DE
Simonian, N
Lajaunie, M
Miller, DE
Wende, K
Martens-Davidson, A
Kinkel, RP
Munschauer, FE
Brownscheidle, CM
Citation: Jh. Simon et al., A longitudinal study of brain atrophy in relapsing multiple sclerosis, NEUROLOGY, 53(1), 1999, pp. 139-148
Authors:
Goodkin, DE
Priore, RL
Wende, KE
Campion, M
Bourdette, DN
Herndon, RM
Fischer, JS
Jacobs, LD
Cookfair, DL
Rudick, RA
Richert, JR
Salazar, AM
Granger, CV
Simon, JH
Alam, JJ
Bartoszak, DM
Braiman, J
Brownscheidle, CM
Coats, ME
Cohan, SL
Dougherty, DS
Kinkel, RP
Mass, MK
Munschauer, FE
Pullicino, PM
Scherokman, BJ
Weinstock-Guttman, B
Whitham, RH
Citation: De. Goodkin et al., Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials, MULT SCLER, 4(6), 1998, pp. 480-486
Authors:
Herndon, RM
Citation: Rm. Herndon, Treatment of multiple sclerosis with the interferon-beta s - Comparative risks and benefits, BIODRUGS, 10(6), 1998, pp. 463-470
Authors:
Herndon, RM
Jacobs, L
Citation: Rm. Herndon et L. Jacobs, Interferons should be used to treat most patients with MS, ARCH NEUROL, 55(12), 1998, pp. 1581-1583
Risultati:
1-13
|